Compounds > 1-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid
Page last updated: 2024-12-07
1-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid
1-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid, also known as **DTPA-NCS**, is a chelating agent used in various research areas, particularly in:
**1. Radiolabeling and Imaging:**
* **Radiolabeling:** DTPA-NCS is a key component in radiolabeling procedures. It reacts with proteins, peptides, or other biomolecules to create stable complexes with radioisotopes like technetium-99m (Tc-99m). This allows for the creation of radiopharmaceuticals used in diagnostic imaging techniques like Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET).
* **Targeted Imaging:** By attaching DTPA-NCS to specific antibodies or targeting molecules, researchers can create radiolabeled probes that can bind to specific cells or tissues. This allows for the visualization and study of biological processes at the cellular level, contributing to the development of new diagnostic tools for various diseases.
**2. Cell Biology and Bioconjugation:**
* **Cell Labeling:** DTPA-NCS is used to label cells, allowing researchers to track their movement, distribution, and interactions with other cells or substances.
* **Bioconjugation:** By reacting with primary amines, DTPA-NCS can be used to attach a variety of molecules to proteins or other biomolecules. This is valuable for studying protein function, developing targeted drug delivery systems, and creating novel biomaterials.
**Importance in Research:**
DTPA-NCS's importance lies in its ability to facilitate:
* **Improved Imaging Techniques:** By enabling the creation of stable radiopharmaceuticals, DTPA-NCS contributes to advancements in diagnostic imaging, leading to earlier disease detection and more effective treatment strategies.
* **Targeted Drug Delivery:** The ability to attach various molecules to biomolecules through DTPA-NCS opens doors to targeted drug delivery systems, allowing for more efficient and specific delivery of therapeutic agents to target cells.
* **Enhanced Cell Biology Studies:** By enabling cell labeling and bioconjugation, DTPA-NCS aids researchers in understanding complex biological processes and gaining insights into cellular interactions and functions.
Overall, DTPA-NCS is a versatile and essential reagent in various research fields, contributing to advancements in imaging techniques, drug delivery, and cell biology studies. Its importance lies in its ability to create stable complexes with diverse biomolecules and radioisotopes, facilitating the development of new diagnostic tools, therapeutic agents, and research methodologies.
Cross-References
ID Source | ID |
PubMed CID | 124173 |
SCHEMBL ID | 6550277 |
MeSH ID | M0153513 |
Synonyms (20)
Synonym |
1-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid |
2-[2-[bis(carboxymethyl)amino]ethyl-[(2s)-2-[bis(carboxymethyl)amino]-3-(4-isothiocyanatophenyl)propyl]amino]acetic acid |
5h79013y15 , |
scn-bz-dtpa |
1-p-isothiocyanatobenzyl-diethylenetriaminepentaacetic acid |
unii-5h79013y15 |
glycine, n-(2-((2-(bis(carboxymethyl)amino)ethyl)(carboxymethyl)amino)-1-((4-isothiocyanatophenyl)methyl)ethyl)-n-(carboxymethyl)-, (s)- |
102650-30-6 |
citc-dtpa, (s)- |
n-(2-(bis(carboxymethyl)amino)ethyl)-n-((2s)-2-(bis(carboxymethyl)amino)-3-(4-isothiocyanatophenyl)propyl)glycine |
glycine, n-(2-(bis(carboxymethyl)amino)ethyl)-n-((2s)-2-(bis(carboxymethyl)amino)-3-(4-isothiocyanatophenyl)propyl)- |
glycine, n-(2-(bis(carboxymethyl)amino)ethyl)-n-(2-(bis(carboxymethyl)amino)-3-(4-isothiocyanatophenyl)propyl)-, (s)- |
bz-dtpa |
p-scn-benzyl-dtpa, (s)- |
SCHEMBL6550277 |
DTXSID90145439 |
n-{2-[bis(carboxymethyl)amino]ethyl}-n-[(2s)-2-[bis(carboxymethyl)amino]-3-(4-isothiocyanatophenyl)propyl]glycine |
Q27262163 |
CS-0891234 |
HY-156035 |
Research
Studies (11)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 3 (27.27) | 18.7374 |
1990's | 5 (45.45) | 18.2507 |
2000's | 1 (9.09) | 29.6817 |
2010's | 2 (18.18) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.75
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 11.75 (24.57) | Research Supply Index | 2.64 (2.92) | Research Growth Index | 4.38 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 13 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |